Contamination of a Recombinant Hepatitis B Virus Nucleocapsid Preparation with a Human B-Cell Activator

Por Vanlandschoot, Peter, Van Houtte, Freya, Serruys, Benedikte, Leroux-Roels, Geert
Publicado em 2007

Hepatitis B Virus Core Antigen Binds and Activates Naive Human B Cells In Vivo: Studies with a Human PBL-NOD/SCID Mouse Model

Por Cao, Tinghua, Lazdina, Una, Desombere, Isabelle, Vanlandschoot, Peter, Milich, David R., Sällberg, Matti, Leroux-Roels, Geert
Publicado em 2001

Comparison of Serum Humoral Responses Induced by Oral Immunization with the Hepatitis B Virus Core Antigen and the Cholera Toxin B Subunit

Por Broos, Katleen, Janssens, Michiel E., De Goeyse, Ine, Vanlandschoot, Peter, Leroux-Roels, Geert, Geysen, Dirk, Guisez, Yves
Publicado em 2008

VHH selected against the viral spike protein can protect mice against lethal rabies virus challenge

Por Rosseels, Valérie, Vanlandschoot, Peter, Hultberg, Anna, Verrips, Theo, Saunders, Michael, de Haard, Hans, Francart, Aurélie, Kalai, Michael M, Van Gucht, Steven
Publicado em 2011

Selection of Nanobodies that Target Human Neonatal Fc Receptor

Por Andersen, Jan Terje, Gonzalez-Pajuelo, Maria, Foss, Stian, Landsverk, Ole J. B., Pinto, Débora, Szyroki, Alexander, de Haard, Hans J., Saunders, Michael, Vanlandschoot, Peter, Sandlie, Inger
Publicado em 2013

Protective Effect of Different Anti-Rabies Virus VHH Constructs against Rabies Disease in Mice

Por Terryn, Sanne, Francart, Aurélie, Lamoral, Sophie, Hultberg, Anna, Rommelaere, Heidi, Wittelsberger, Angela, Callewaert, Filip, Stohr, Thomas, Meerschaert, Kris, Ottevaere, Ingrid, Stortelers, Catelijne, Vanlandschoot, Peter, Kalai, Michael, Van Gucht, Steven
Publicado em 2014

Enhancement of Polymeric Immunoglobulin Receptor Transcytosis by Biparatopic VHH

Por Emmerson, Chris D., van der Vlist, Els J., Braam, Myrthe R., Vanlandschoot, Peter, Merchiers, Pascal, de Haard, Hans J. W., Verrips, C. Theo, van Bergen en Henegouwen, Paul M. P., Dolk, Edward
Publicado em 2011

CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells

Por Jähnichen, Sven, Blanchetot, Christophe, Maussang, David, Gonzalez-Pajuelo, Maria, Chow, Ken Y., Bosch, Leontien, De Vrieze, Sindi, Serruys, Benedikte, Ulrichts, Hans, Vandevelde, Wesly, Saunders, Michael, De Haard, Hans J., Schols, Dominique, Leurs, Rob, Vanlandschoot, Peter, Verrips, Theo, Smit, Martine J.
Publicado em 2010

Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules

Por Hultberg, Anna, Temperton, Nigel J., Rosseels, Valérie, Koenders, Mireille, Gonzalez-Pajuelo, Maria, Schepens, Bert, Ibañez, Lorena Itatí, Vanlandschoot, Peter, Schillemans, Joris, Saunders, Michael, Weiss, Robin A., Saelens, Xavier, Melero, José A., Verrips, C. Theo, Van Gucht, Steven, de Haard, Hans J.
Publicado em 2011

Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo

Por Maussang, David, Mujić-Delić, Azra, Descamps, Francis J., Stortelers, Catelijne, Vanlandschoot, Peter, Stigter-van Walsum, Marijke, Vischer, Henry F., van Roy, Maarten, Vosjan, Maria, Gonzalez-Pajuelo, Maria, van Dongen, Guus A. M. S., Merchiers, Pascal, van Rompaey, Philippe, Smit, Martine J.
Publicado em 2013